{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zheng P"],"funding":["NIBIB NIH HHS","National Institute of General Medical Sciences","NIGMS NIH HHS","National Institute of Biomedical Imaging and Bioengineering"],"pagination":["e2305110"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922205"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["20(6)"],"pubmed_abstract":["Functional disorders of the thyroid remain a global challenge and have profound impacts on human health. Serving as the barometer for thyroid function, thyroid-stimulating hormone (TSH) is considered the single most useful test of thyroid function. However, the prevailing TSH immunoassays rely on two types of antibodies in a sandwich format. The requirement of repeated incubation and washing further complicates the issue, making it unable to meet the requirements of the shifting public health landscape that demands rapid, sensitive, and low-cost TSH tests. Herein, a systematic study is performed to investigate the clinical translational potential of a single antibody-based biosensing platform for the TSH test. The biosensing platform leverages Raman spectral variations induced by the inter"],"journal":["Small (Weinheim an der Bergstrasse, Germany)"],"pubmed_title":["Quantitative Detection of Thyroid-Stimulating Hormone in Patient Samples with a Nanomechanical Single-Antibody Spectro-Immunoassay."],"pmcid":["PMC10922205"],"funding_grant_id":["DP2 GM128198","1R35GM149272","R35 GM149272","DP2GM128198","P41 EB015871","2‐P41‐EB015871","2-P41-EB015871"],"pubmed_authors":["Barman I","Wu L","Hanson WA","Raj P","Zheng P","Szabo M","Mizutani T"],"additional_accession":[]},"is_claimable":false,"name":"Quantitative Detection of Thyroid-Stimulating Hormone in Patient Samples with a Nanomechanical Single-Antibody Spectro-Immunoassay.","description":"Functional disorders of the thyroid remain a global challenge and have profound impacts on human health. Serving as the barometer for thyroid function, thyroid-stimulating hormone (TSH) is considered the single most useful test of thyroid function. However, the prevailing TSH immunoassays rely on two types of antibodies in a sandwich format. The requirement of repeated incubation and washing further complicates the issue, making it unable to meet the requirements of the shifting public health landscape that demands rapid, sensitive, and low-cost TSH tests. Herein, a systematic study is performed to investigate the clinical translational potential of a single antibody-based biosensing platform for the TSH test. The biosensing platform leverages Raman spectral variations induced by the inter","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2025-04-18T12:48:49.966Z","creation":"2025-04-06T22:10:29.113Z"},"accession":"S-EPMC10922205","cross_references":{"pubmed":["37752776"],"doi":["10.1002/smll.202305110"]}}